Back to Rankings

ABOS

AcumenA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ABOS vs peer average
92/100
ABOS vs. peer average (A vs. D)
Grade spread
A 2 · B 1 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ANVS is the first available peer comparator.

Annovis Bio is a more advanced Alzheimer’s-focused clinical peer and is useful for comparing event-driven sentiment around central-nervous-system trial readouts and financing risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerANVSAnnovis Bio
ABOS
Acumen
ANVS
Annovis Bio
Grade
A
F
Momentum
72
13
Value
42
41
Sentiment
78
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ANVS

ABOS / ANVS
Grade Position
Above peers
ABOS vs. peer average (A vs. D)
92/100
Momentum
72
ABOS
Value
42
ABOS
Sentiment
78
ABOS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ABOS
1
ANVS
ANVS
F
20/100
+4
2
ALZN
ALZN
F
20/100
+4
3
CGTX
CGTX
C
60/100
+2
4
DTIL
Precision BioSciences Inc Common
A
100/100
Even
5
LFCR
Lifecore Biomedical Inc Common
F
20/100
+4
ANVS is the first peer returned for this comparison set.